Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vernalis plc
Researches and develops pharmaceutical products

Vernalis Plc engages in the research, development, and commercialization of pharmaceutical products under the Tuzistra XR brand.

The company was founded by Keith G. McCullagh in 1986 and is headquartered in Winnersh, United Kingdom.

Number of employees : 103 persons.
Sales per Businesses
20152016Delta
GBP (in Million)%GBP (in Million)%
Pharmaceuticals13.26100%---
Research & Development--8.0466.8%-
Commercial--3.9933.2%-
Sales per Regions
20152016Delta
GBP (in Million)%GBP (in Million)%
Rest of Europe10.2577.4%8.1367.6% -20.68%
Rest of the World2.3217.5%2.7322.7% +18%
North America0.6695%1.169.7% +73.69%
United Kingdom0.0160.1%0.0050% -68.75%
Managers
NameAgeSinceTitle
Ian Garland51-Chief Executive Officer & Executive Director
Peter John Fellner, PhD742003Non-Executive Chairman
David MacKney49-Chief Financial Officer & Executive Director
Pascal Borderies, MD-2014Senior Vice President-Medical Affairs
Carol C. Ferguson702003Senior Independent Non-Executive Director
Nigel Sheail512011Independent Non-Executive Director
Ian David Gilham, PhD572015Independent Non-Executive Director
Lisa Amster Schoenberg, MBA502015Non-Executive Director
Kevin Kissane612010Secretary & General Counsel
Mike Wood-2004Research Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 526,352,521 520,442,829 98.9% 0 0.0% 98.9%
Shareholders
NameEquities%
Invesco Asset Management Ltd. 194,441,770 36.9%
Woodford Investment Management LLP 157,226,138 29.9%
GAM London Ltd. 47,861,787 9.09%
Legal & General Investment Management Ltd. 30,642,580 5.82%
Aviva Investors Global Services Ltd. 26,309,928 5.00%
Rothschild Bank AG 12,129,000 2.30%
Majedie Asset Management Ltd. 8,179,958 1.55%
EdenTree Investment Management Ltd. 4,750,000 0.90%
River & Mercantile Asset Management LLP 3,008,987 0.57%
Hargreaves Lansdown Asset Management Ltd. 2,912,000 0.55%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
VERNALIS PLC-4.41%210
INCYTE CORPORATION14.78%21 681
QUINTILES IMS HOLDINGS..-0.60%18 609
CELLTRION, INC.--.--%10 542
LONZA GROUP AG4.14%9 661
ALKERMES PLC0.45%8 485
SEATTLE GENETICS, INC.11.88%8 357
QIAGEN NV-0.39%6 690
UNITED THERAPEUTICS CO..6.53%6 481
IONIS PHARMACEUTICALS ..-1.44%5 714
ICON PLC7.47%4 531
ACADIA PHARMACEUTICALS..12.03%3 913
CHARLES RIVER LABORATO..5.03%3 787
PAREXEL INTERNATIONAL ..8.03%3 782
BIO-TECHNE CORP-3.72%3 694
PRA HEALTH SCIENCES IN..1.12%3 423
ALNYLAM PHARMACEUTICAL..2.86%3 305
GALAPAGOS4.89%3 148
INTREXON CORP3.17%2 973
INC RESEARCH HOLDINGS ..-3.14%2 732
IRONWOOD PHARMACEUTICA..-0.59%2 223
Sector Biotechnology & Medical Research - NEC
Vernalis plc : Connections
Biosurfit SA
The Institute of Chartered Accountants of Scotland
Bayer HealthCare
Multiplicom NV
Concepta Diagnostics Ltd.
Chartered Accountants Compensation Scheme Ltd.
Stowheath Ltd.
Company contact information
Vernalis Plc
100 Berkshire Place
Wharfedale Road
Winnersh, Berkshire RG41 5RD

Phone : +44.118.938.0000
Fax : +44.118.938.0001
Web : www.vernalis.com
© 2017 People , Fundamentals and Ownership